Adolescents represent a growing proportion of people living with HIV worldwide and the
highest risk population group for treatment attrition and AIDS-related mortality. There is an …

Introduction Globally, an estimated 30% of new HIV infections occur among adolescents (15–
24 years), most of whom reside in sub-Saharan Africa. Moreover, HIV-related mortality …

Introduction Adolescents living with HIV are an underserved population, with poor retention
in HIV health care services and high mortality, who are in need of targeted effective …

Retention and adherence: global challenges for the long-term... : Current Opinion in HIV
and AIDS Retention and adherence: global challenges for the long-term care of …

Adolescents and youth living with HIV have poorer antiretroviral treatment (ART) adherence
and viral suppression outcomes than all other age groups. Effective interventions promoting …

Objectives Adolescents living with HIV face substantial difficulties in accessing HIV care
services and have worse treatment outcomes than other age groups. The objective of this …

Background Achieving and maintaining high levels of medication adherence are required to
achieve the full benefits of antiretroviral therapy (ART), yet suboptimal adherence among …

Objective: This systematic review aimed to identify antiretroviral therapy (ART) adherence
interventions specifically targeting adolescents and young adults (defined as ages 13–24) …

Antiretroviral therapy adherence and retention in care in mi... : Current Opinion in HIV and AIDS
Antiretroviral therapy adherence and retention in care in middle-income and low-income …

Adolescents living in low-and middle-income countries (LMICs) are disproportionately
burdened by the global HIV/AIDS pandemic. Maintaining medication adherence is vital to …